Exclusive

Publication

Byline

Bosnia and Herzegovina vs Qatar Prediction: Who Will Win Today's BIH vs QAT FIFA World Cup Match In Seattle? Match Preview, Round Of 32 Qualification Scenario and Projected Score

India, June 24 -- As we reach the final matchday of Group B, Bosnia and Herzegovina and Qatar are gearing up for a highly anticipated showdown at the Seattle Stadium, with both teams chasing a knockou... Read More


FIFA World Cup 2026: Neymar named on bench for Brazil against Scotland, Rayan replaces Raphinha

Florida, June 24 -- Neymar Jr. has been named on the bench for Brazil's final FIFA World Cup 2026 Group C match against Scotland, marking his return to the squad after recovering from a calf injury. M... Read More


Iran President Pezeshkian invites PM Modi to attend former Supreme Leader Ali Khamenei's state funeral: Sources

Tehran, June 24 -- Iranian President Masoud Pezeshkian has invited Prime Minister Narendra Modi to the state funeral and burial ceremonies for Ali Khamenei, the former Supreme Leader of Iran, sources ... Read More


NYT Spelling Bee Answers for June 24, 2026: Complete 63-Word Solution List, Pangram, Hints, and Genius Score

New Delhi, June 24 -- The NYT Spelling Bee official rules and gameplay define a deceptively simple challenge that continues to dominate daily word puzzle culture. Built around a constrained letter set... Read More


Rotten fruits, dead insects found at Hyderabad supermarket

Hyderabad, June 24 -- A food safety inspection by Cyberabad Municipal Corporation at Vijetha Supermarket in Tellapur on Wednesday, June 24, uncovered rotten fruits, dead insects on food racks and expi... Read More


Cold call to dinner with Mark Zuckerberg, how Kunal Shah clinched the top job at WhatsApp

New Delhi, June 24 -- Meta Platforms Inc.'s decision to hand leadership of WhatsApp to Kunal Shah, one of India's most prominent angel investors and the founder of fintech star Cred, started with a co... Read More


Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, June 24 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating ... Read More


Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, June 24 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Pla... Read More


Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, June 24 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solut... Read More


Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, June 24 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib M... Read More